Nā Huahana Hōʻailona Hōʻailona

  • 01 China Hawaiian Pharmaceutical Market

    eli lilly

    Hiki iā China ke kūʻai aku i kaʻoihana kūʻai luaʻoi lua o ka honua ma ka United States, ma ka makahiki 2015, e like me kaʻike IMS Health.

    Ka Pākēkī kūʻai ma 2011: $ 63.9 piliona

    Ka heluna kanaka: 1.3 piliona

    Nā Hana Hana: ʻokoʻa loa me nāʻoihanaʻoi aku o 3,000, nā hui nui a me nā lāʻau lapaʻau.

    ʻO Branded vs. Generic: Generics e pili ana i 64 pakeneka o ka mākeke ma ke kumukūʻai, me lāʻau lapaʻau ma luna o kaʻaʻa ma kahi o 26 pakeneka.

    Ka mahele: Māhele hoʻolaha māhele'āina e hoʻohana ana i nā mea likeʻole.

    Kākoʻo nui: Nā hale kaulike (56 pakeneka), nā'ahamele (24 pakeneka), nā kikowaena ola kino (20 pakeneka)

    Nā Pūnaewele: IMS Ola, PharmaVentures, Espicom

  • 02 Brazil Market Pharmaceutical

    Ka Pākēkī kūʻai ma 2011: $ 22.7 pelika

    Ka heluna kanaka: 206 miliona

    Nā Hana Hana:ʻO kaʻoihana āpau i kēia manawa ma kaʻoihana kūʻai kālepa o Brazil akā ua ulu nui ka'āina ma EMS, Aché, Eurofarma, a me Hypermarcas.

    ʻO Branded vs. Generic: Ke poʻo o Generics (70 pakeneka) e alakaʻi i ke kālepa, a ukaliʻia e ka luna kūʻai (17%) a me ka patented (12 pakeneka). ʻO kaʻoihana nui o Brazil ka mea nui loa i waena o nā lāhuiʻAmelika Latin.

    Ka Laha:ʻO kahi lima o nā hui nui e hoʻomalu i ka māheleʻana akā aia iʻoi aku ka nui aku o 3,000 mau mea kūʻai nui.

    Nui Ke Kūʻai: Nā kālepa a me ke kūʻaiʻana (71 pakeneka), nā halemai (8 pakeneka)

    Hoʻonuiʻia ka uluʻana i ka makahiki 2015: 7 a 12 pakeneka

    Nā Pūnaewele: IMS Ola, PharmaVentures, Epsicon

  • 03 Hawaiian Market Pharmaceutical Market

    Ua komo nui nā pharmas nui ma ka'āina ma hope o ka hoʻomaikaʻi houʻana i ka hoʻoponopono kānāwai, e piʻi ana i nā hualoaʻa, nāʻoihana akamai a me nā manawa kūpono no kaʻoihana'elike .

    Ka Pākēkī kūʻai ma 2011: $ 18.2 pākēka

    Ka helu kanaka: 464 miliona hui

    Nā Hana Hana: GlaxoSmithKline, Pfizer, Sanofi-Aventis, Laboratories Ranbaxy a me Takeda Pharmaceutical e hana nei ma ka'āina.

    ʻO Branded vs. Generic: He ikaika ikaika ka Vietnam (90% o ka hōʻuluʻulu), aʻo kaʻoihana kūʻai o Singapore he 20 pakeneka o ka nui. Ke hoʻonui nei ka lālā o luna ma waho o ka'āina.

    Ka Laha:ʻO Zuellig Pharma nā mea nui loa

    Kākoʻo nui : Kūkala ma waena o nā'āina

    Hoʻonuiʻia ka uluʻana i ka makahiki 2015: 7 a 10 pakeneka

    Nā Pūnaewele: IMS Ola, PharmaVentures, RNCOS

  • 04 Russia Market Shop

    Ua hoʻonui ka nui o nāʻenehana i kā lākou kūʻokoʻa i ka māka kūʻai ma Russia ma 2011 me Novartis, kahi i hoʻomaka i ke kūkuluʻana i kahi mea hana ma St Petersburg a me AstraZeneca i hoʻomaka i ke kūkuluʻana i kahi mea kanu hou ma ka Kaluga.

    Ka Pākēkī Makahiki i 2010: $ 18.7 pelika

    Ka heluna kanaka: 142 miliona

    Nā Hana Hana:ʻO ka hapa nui o nā'āina he mau multinationals e lawelawe ana i loko

    Branded vs. Generic: Ua hoʻomauʻia kaʻoihana kūʻai o Russia ma nā huaʻano i hanaʻia ma ka'āina akā aia ka piʻiʻana o ka nui o nā generics ma nā multinational companies.

    Ka Lakina: I ka makahiki 2010,ʻo nā mea kūʻai 10ʻoi loa i piha i 90% o ka māhele.

    Kākoʻo nui: Nā halemai, nā hui mālama mālama, nā keʻena aupuni, nā mea kūʻai kūʻai lāʻau.

    Hoʻonuiʻia ka uluʻana i ka makahiki 2015: 10 a 12 pakeneka

    Pūnaewele: Espicom, IMS Haukino, PākīpikaʻAmelika Hui PūʻIa, DSM Group

  • 05 India makai kūʻai

    I kēia manawa, aiaʻo ia ma kahi māhele o ke ao holoʻokoʻa ma kahi kūʻai kūʻai lāʻau lapaʻau me 3,500 mau mea kūʻai huaʻai ma ka hoʻounaʻana aku e pili ana i $ 10 biliona i kēlā me kēia makahiki i nā'āina he 100, ke manaʻo neiʻo India e hoʻonui i kāna kūʻaiʻana i nāʻoihana'ē aʻe,ʻoʻAmelika Hui Pūʻia a meʻEulopa. ʻO Dr. Reddy's, kekahi o nā mea kūʻai nui loa o India, ua hoʻokumu nuiʻo ia ma ka mākele oʻAmelika.

    ʻO ka hanaʻana i nā lāʻau lapaʻau mele inoa a me nā ho'āʻoʻana i nā hoʻokolohua hōʻailona no nā multinationals kekahi mau māhele o ka uluʻana ma waena o ke kālepa kūʻai India.

    Ka Pākēkī kūʻai ma 2011: $ 15.7 pākēka

    Ka piʻipili: 1.2 biliona

    Nā Hana Hana: Nā kūʻaiʻana o nāʻano holoholona i nā mākeke kūʻokoʻa me ka US a meʻEulopa.

    ʻO Branded vs. Generic:ʻO Branded generics kahi o 90% o ka hoʻohanaʻana i nā lāʻau kūʻai lāʻau, hoʻohanaʻia nā lāʻau lapaʻau e 16 percent o ka nui o nā lāʻau i kūʻaiʻia.

    Kōpana:ʻO India e hilinaʻi ana i kahi luna hoʻolaha a me ka hoʻounaʻana (CFA) pūnaewele hoʻolaha. ʻOiai ka piʻiʻana o ka poʻe kālepa a me nāʻoihana kūʻai liʻiliʻi e loaʻa ana i ka loaʻaʻole ka pono o ka māheleʻana, ma nāʻano kaiāulu paha.

    Kākoʻo nui: Nakamai (70 pakeneka), halemai (30 pakeneka)

    Hoʻonuiʻia ka uluʻana i ka makahiki 2015: 12 a 16 pakeneka

    Nā Pūnaewele: IMS Health, Epsicon, Kamaliʻi hōʻike

  • 06 Turkey Market Pharmaceutical

    ʻO kaʻoihana olakino wikiwiki a Turkey a me nā lāhui nui loa ma waena o nā lāhuiʻo Middle East. ʻO nāʻoihana'ē aʻe e pili ana i kahi o 80 pakeneka o nāʻoihanaʻoihana kālai'āina. MaʻApelila 2012 Loaʻaʻo Amgen he 95.6 pakeneka o nā'āpana o Mustafa Nevzat Pharmaceuticals (MN), he hui hoʻopōlaki Turkish no kahi $ 700 miliona. He kūlekana kūpono nā kumukūʻai o Turkey i ka makahiki, a hoʻohana i kahi $ 50 i kēlā me kēia poʻokela ma nā mea lapaʻau i kēlā me kēia makahiki, e like me ka'ōlelo a Egon Zehnder International.

    Ka Pākēkī kūʻai ma 2011: $ 11.6 pākēka

    Nā Hana Hana: No 85 mau mea hana kaiaulu a lehulehu

    ʻO Branded vs. Generic:ʻO Generics e pili ana i kahi 50% o ka volume a 35% o ka waiwai. ʻO ka luna kūʻai he 11 pakeneka o ka nui o ka mākaʻi.

    Holaha: ʻO nā meaʻelua o ka māhele,ʻo Hedef a me Selcuk Ecza, he 70 pakeneka o ka maheleʻana a he 15% o ka hapanui o ka hapakū o nā hui hui.

    Luna Nui: E māheleʻia i waena o nā kauka, nā halemai, a me nā keʻena

    Hoʻonuiʻia ka uluʻana ma 2015: 10 a 14 pakeneka

    Nā Pūnaewele: IMS Health, PharmaVentures, Kamaliʻi hōʻike